{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T04:13:50Z","timestamp":1772079230717,"version":"3.50.1"},"reference-count":112,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:00:00Z","timestamp":1772064000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:00:00Z","timestamp":1772064000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No.82473522"],"award-info":[{"award-number":["No.82473522"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"he Innovation Capability Support Plan of Shaanxi Health Commission","award":["No.2024TD-15"],"award-info":[{"award-number":["No.2024TD-15"]}]},{"name":"the Key Medical Research Plan of Xi\u2019an City","award":["No.24YXYJ0001"],"award-info":[{"award-number":["No.24YXYJ0001"]}]},{"name":"the Special Support Program for High-Level Talents of Shaanxi Province"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflamm. Res."],"DOI":"10.1007\/s00011-025-02172-8","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T02:29:17Z","timestamp":1772072957000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Advances in the lectin pathway in systemic lupus erythematosus: from clinical correlations and mechanisms to targeted interventions"],"prefix":"10.1007","volume":"75","author":[{"given":"Rongfang","family":"Feng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yufei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaning","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumin","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,26]]},"reference":[{"key":"2172_CR1","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.1016\/S0140-6736(19)30237-5","volume":"393","author":"L Durcan","year":"2019","unstructured":"Durcan L, O\u2019Dwyer T, Petri M. Management strategies and future directions for systemic lupus erythematosus in adults. Lancet. 2019;393:2332\u201343. https:\/\/doi.org\/10.1016\/S0140-6736(19)30237-5.","journal-title":"Lancet"},{"key":"2172_CR2","doi-asserted-by":"publisher","first-page":"e447","DOI":"10.1016\/S2665-9913(24)00090-0","volume":"6","author":"E Bolla","year":"2024","unstructured":"Bolla E, Semb AG, Kerola AM, et al. Prevalence and target attainment of traditional cardiovascular risk factors in patients with systemic lupus erythematosus: a cross-sectional study including 3401 individuals from 24 countries. Lancet Rheumatol. 2024;6:e447\u201359. https:\/\/doi.org\/10.1016\/S2665-9913(24)00090-0.","journal-title":"Lancet Rheumatol"},{"key":"2172_CR3","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1136\/annrheumdis-2017-211663","volume":"76","author":"MG Tektonidou","year":"2017","unstructured":"Tektonidou MG, Lewandowski LB, Hu J, et al. Survival in adults and children with systemic lupus erythematosus: a systematic review and bayesian meta-analysis of studies from 1950 to 2016. Ann Rheum Dis. 2017;76:2009\u201316. https:\/\/doi.org\/10.1136\/annrheumdis-2017-211663.","journal-title":"Ann Rheum Dis"},{"key":"2172_CR4","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s40265-022-01824-x","volume":"83","author":"D Roccatello","year":"2023","unstructured":"Roccatello D, Sciascia S, Rossi D, et al. Refractory systemic lupus erythematosus: identification and pharmacological management. Drugs. 2023;83:117\u201334. https:\/\/doi.org\/10.1007\/s40265-022-01824-x.","journal-title":"Drugs"},{"key":"2172_CR5","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1136\/annrheumdis-2014-205287","volume":"73","author":"J Leffler","year":"2014","unstructured":"Leffler J, Bengtsson AA, Blom AM. The complement system in systemic lupus erythematosus: an update. Ann Rheum Dis. 2014;73:1601\u20136. https:\/\/doi.org\/10.1136\/annrheumdis-2014-205287.","journal-title":"Ann Rheum Dis"},{"key":"2172_CR6","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.3389\/fimmu.2019.01667","volume":"10","author":"X Wang","year":"2019","unstructured":"Wang X, Xia Y. Anti-double stranded DNA antibodies: origin, pathogenicity, and targeted therapies. Front Immunol. 2019;10:1667. https:\/\/doi.org\/10.3389\/fimmu.2019.01667.","journal-title":"Front Immunol"},{"key":"2172_CR7","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1007\/s00134-024-07611-4","volume":"50","author":"E Azoulay","year":"2024","unstructured":"Azoulay E, Zuber J, Bousfiha AA, et al. Complement system activation: bridging physiology, pathophysiology, and therapy. Intensive Care Med. 2024;50:1791\u2013803. https:\/\/doi.org\/10.1007\/s00134-024-07611-4.","journal-title":"Intensive Care Med"},{"key":"2172_CR8","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1056\/NEJMoa2414719","volume":"393","author":"RF van Vollenhoven","year":"2025","unstructured":"van Vollenhoven RF, Wang L, Merrill JT, et al. A phase 3 trial of telitacicept for systemic lupus erythematosus. N Engl J Med. 2025;393:1475\u201385. https:\/\/doi.org\/10.1056\/NEJMoa2414719.","journal-title":"N Engl J Med"},{"key":"2172_CR9","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1136\/ard-2023-224762","volume":"83","author":"A Fanouriakis","year":"2024","unstructured":"Fanouriakis A, Kostopoulou M, Andersen J, et al. Eular recommendations for the management of systemic lupus erythematosus: 2023 update. Ann Rheum Dis. 2024;83:15\u201329. https:\/\/doi.org\/10.1136\/ard-2023-224762.","journal-title":"Ann Rheum Dis"},{"key":"2172_CR10","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.93685","volume":"17","author":"A Manchikalapati","year":"2025","unstructured":"Manchikalapati A, Zinser Peniche P, Machin NC. Complement-mediated thrombotic microangiopathies with predominant renal involvement in a patient with lupus nephritis. Cureus. 2025;17:e93685. https:\/\/doi.org\/10.7759\/cureus.93685.","journal-title":"Cureus"},{"key":"2172_CR11","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.1093\/rheumatology\/kev307","volume":"54","author":"MC Pickering","year":"2015","unstructured":"Pickering MC, Ismajli M, Condon MB, et al. Eculizumab as rescue therapy in severe resistant lupus nephritis. Rheumatology (Oxford). 2015;54:2286\u20138. https:\/\/doi.org\/10.1093\/rheumatology\/kev307.","journal-title":"Rheumatology (Oxford)"},{"key":"2172_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25031566","author":"J Dob\u00f3","year":"2024","unstructured":"Dob\u00f3 J, Kocsis A, Farkas B, et al. The lectin pathway of the complement system-activation, regulation, disease connections and interplay with other (proteolytic) systems. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/ijms25031566.","journal-title":"Int J Mol Sci"},{"key":"2172_CR13","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.kint.2023.04.029","volume":"104","author":"J Barratt","year":"2023","unstructured":"Barratt J, Lafayette RA, Zhang H, et al. Iga nephropathy: the lectin pathway and implications for targeted therapy. Kidney Int. 2023;104:254\u201364. https:\/\/doi.org\/10.1016\/j.kint.2023.04.029.","journal-title":"Kidney Int"},{"key":"2172_CR14","doi-asserted-by":"publisher","first-page":"10587","DOI":"10.1038\/ncomms10587","volume":"7","author":"M Serna","year":"2016","unstructured":"Serna M, Giles JL, Morgan BP, et al. Structural basis of complement membrane attack complex formation. Nat Commun. 2016;7:10587. https:\/\/doi.org\/10.1038\/ncomms10587.","journal-title":"Nat Commun"},{"key":"2172_CR15","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S1074-7613(01)00161-3","volume":"15","author":"MR Dahl","year":"2001","unstructured":"Dahl MR, Thiel S, Matsushita M, et al. Masp-3 and its association with distinct complexes of the mannan-binding lectin complement activation pathway. Immunity. 2001;15:127\u201335.","journal-title":"Immunity"},{"key":"2172_CR16","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/1756-185X.14017","volume":"24","author":"Z-C Yuan","year":"2021","unstructured":"Yuan Z-C, Xu W-D, Lan Y-Y, et al. Association of MBL2 gene polymorphisms and systemic lupus erythematosus susceptibility: a meta-analysis. Int J Rheum Dis. 2021;24:147\u201358. https:\/\/doi.org\/10.1111\/1756-185X.14017.","journal-title":"Int J Rheum Dis"},{"key":"2172_CR17","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1177\/0961203320939156","volume":"29","author":"H Mahto","year":"2020","unstructured":"Mahto H, Pati A, Sahu SK, et al. Association of MBL-2 gene polymorphisms with systemic lupus erythematosus: an updated meta-analysis and trial sequential analysis. Lupus. 2020;29:1227\u201337. https:\/\/doi.org\/10.1177\/0961203320939156.","journal-title":"Lupus"},{"key":"2172_CR18","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s10238-021-00758-0","volume":"22","author":"H Ebrahimiyan","year":"2022","unstructured":"Ebrahimiyan H, Mostafaei S, Aslani S, et al. Association between complement gene polymorphisms and systemic lupus erythematosus: a systematic review and meta-analysis. Clin Exp Med. 2022;22:427\u201338. https:\/\/doi.org\/10.1007\/s10238-021-00758-0.","journal-title":"Clin Exp Med"},{"key":"2172_CR19","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1177\/09612033211066457","volume":"31","author":"CF Saldanha","year":"2022","unstructured":"Saldanha CF, da Kniphoff Silva G, Glesse N, et al. MBL2 gene polymorphisms and its relation to infection in Brazilian systemic lupus erythematosus patients: a 10-years follow-up study. Lupus. 2022;31:279\u201386. https:\/\/doi.org\/10.1177\/09612033211066457.","journal-title":"Lupus"},{"key":"2172_CR20","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.humimm.2012.09.003","volume":"74","author":"AK Panda","year":"2013","unstructured":"Panda AK, Parida JR, Tripathy R, et al. Low producer MBL genotypes are associated with susceptibility to systemic lupus erythematosus in Odisha, India. Hum Immunol. 2013;74:114\u20139. https:\/\/doi.org\/10.1016\/j.humimm.2012.09.003.","journal-title":"Hum Immunol"},{"key":"2172_CR21","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.3899\/jrheum.100158","volume":"37","author":"LN Troelsen","year":"2010","unstructured":"Troelsen LN, Garred P, Christiansen B, et al. Genetically determined serum levels of mannose-binding lectin correlate negatively with common carotid intima-media thickness in systemic lupus erythematosus. J Rheumatol. 2010;37:1815\u201321. https:\/\/doi.org\/10.3899\/jrheum.100158.","journal-title":"J Rheumatol"},{"key":"2172_CR22","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.clim.2007.08.020","volume":"125","author":"L Jakab","year":"2007","unstructured":"Jakab L, Laki J, Sallai K, et al. Association between early onset and organ manifestations of systemic lupus erythematosus (SLE) and a down-regulating promoter polymorphism in the MBL2 gene. Clin Immunol. 2007;125:230\u20136. https:\/\/doi.org\/10.1016\/j.clim.2007.08.020.","journal-title":"Clin Immunol"},{"key":"2172_CR23","doi-asserted-by":"publisher","first-page":"541","DOI":"10.3899\/jrheum.150884","volume":"43","author":"RC Ho","year":"2016","unstructured":"Ho RC, Ong H, Thiaghu C, et al. Genetic variants that are associated with neuropsychiatric systemic lupus erythematosus. J Rheumatol. 2016;43:541\u201351. https:\/\/doi.org\/10.3899\/jrheum.150884.","journal-title":"J Rheumatol"},{"key":"2172_CR24","doi-asserted-by":"publisher","first-page":"3693","DOI":"10.1038\/s41598-020-60523-3","volume":"10","author":"A Kieninger-Gr\u00e4fitsch","year":"2020","unstructured":"Kieninger-Gr\u00e4fitsch A, Vogt S, Ribi C, et al. No association of complement mannose-binding lectin deficiency with cardiovascular disease in patients with systemic lupus erythematosus. Sci Rep. 2020;10:3693. https:\/\/doi.org\/10.1038\/s41598-020-60523-3.","journal-title":"Sci Rep"},{"key":"2172_CR25","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1159\/000486552","volume":"139","author":"DM Costa","year":"2018","unstructured":"Costa DM, Valente LM, Vajgel Fernandes G, et al. Mannose-binding lectin2 gene polymorphism and IgG4 in membranous nephropathy. Nephron. 2018;139:181\u20138. https:\/\/doi.org\/10.1159\/000486552.","journal-title":"Nephron"},{"key":"2172_CR26","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.3899\/jrheum.100961","volume":"38","author":"Y-C Tsai","year":"2011","unstructured":"Tsai Y-C, Yeh K-W, Yao T-C, et al. Mannose-binding lectin expression genotype in pediatric-onset systemic lupus erythematosus: associations with susceptibility to renal disease and protection against infections. J Rheumatol. 2011;38:1429\u201335. https:\/\/doi.org\/10.3899\/jrheum.100961.","journal-title":"J Rheumatol"},{"key":"2172_CR27","doi-asserted-by":"publisher","first-page":"e155","DOI":"10.1055\/a-2087-0314","volume":"7","author":"SR Vils","year":"2023","unstructured":"Vils SR, Troldborg A, Hvas A-M, et al. Platelets and the lectin pathway of complement activation in patients with systemic lupus erythematosus or antiphospholipid syndrome. TH Open. 2023;7:e155\u201367. https:\/\/doi.org\/10.1055\/a-2087-0314.","journal-title":"TH Open"},{"key":"2172_CR28","doi-asserted-by":"publisher","first-page":"1328658","DOI":"10.3389\/fimmu.2023.1328658","volume":"14","author":"M Cedzy\u0144ski","year":"2023","unstructured":"Cedzy\u0144ski M, \u015awierzko AS. Collectins and ficolins in neonatal health and disease. Front Immunol. 2023;14:1328658. https:\/\/doi.org\/10.3389\/fimmu.2023.1328658.","journal-title":"Front Immunol"},{"key":"2172_CR29","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/1730996","volume":"2022","author":"SR Gil-Qui\u00f1ones","year":"2022","unstructured":"Gil-Qui\u00f1ones SR, Gutierrez-Casta\u00f1eda L, Larios-Salazar L, et al. Effect of polymorphisms in the fcn1, fcn2, and fcn3 genes on the susceptibility to develop rheumatoid arthritis: a systematic review. Int J Rheumatol. 2022;2022:1730996. https:\/\/doi.org\/10.1155\/2022\/1730996.","journal-title":"Int J Rheumatol"},{"key":"2172_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/ahg.12129","volume":"80","author":"C Addobbati","year":"2016","unstructured":"Addobbati C, de Azev\u00eado SJ, Tavares NAC, et al. Ficolin gene polymorphisms in systemic lupus erythematosus and rheumatoid arthritis. Ann Hum Genet. 2016;80:1\u20136. https:\/\/doi.org\/10.1111\/ahg.12129.","journal-title":"Ann Hum Genet"},{"key":"2172_CR31","doi-asserted-by":"publisher","DOI":"10.1177\/0961203319856089","author":"MA Elkoumi","year":"2019","unstructured":"Elkoumi MA, Emam AA, Allah MAN, et al. Association of ficolin-2 gene polymorphisms and susceptibility to systemic lupus erythematosus in Egyptian children and adolescents: a multicenter study. Lupus. 2019. https:\/\/doi.org\/10.1177\/0961203319856089.","journal-title":"Lupus"},{"key":"2172_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2023.103166","volume":"143","author":"L Lindel\u00f6f","year":"2024","unstructured":"Lindel\u00f6f L, Rantap\u00e4\u00e4-Dahlqvist S, Lundtoft C, et al. A survey of ficolin-3 activity in systemic lupus erythematosus reveals a link to hematological disease manifestations and autoantibody profile. J Autoimmun. 2024;143:103166. https:\/\/doi.org\/10.1016\/j.jaut.2023.103166.","journal-title":"J Autoimmun"},{"key":"2172_CR33","doi-asserted-by":"publisher","first-page":"757","DOI":"10.3899\/jrheum.080361","volume":"36","author":"T Andersen","year":"2009","unstructured":"Andersen T, Munthe-Fog L, Garred P, et al. Serum levels of ficolin-3 (Hakata antigen) in patients with systemic lupus erythematosus. J Rheumatol. 2009;36:757\u20139. https:\/\/doi.org\/10.3899\/jrheum.080361.","journal-title":"J Rheumatol"},{"key":"2172_CR34","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1080\/08820139.2022.2110503","volume":"51","author":"E Oliveira Cavalcanti","year":"2022","unstructured":"Oliveira Cavalcanti E, Freitas Lidani KC, de Freitas Oliveira Tor\u00e9 C, et al. MASP1 gene polymorphism and masp-3 serum levels in patients with chronic chagas disease. Immunol Invest. 2022;51:2108\u201321. https:\/\/doi.org\/10.1080\/08820139.2022.2110503.","journal-title":"Immunol Invest"},{"key":"2172_CR35","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1111\/j.1365-3083.2007.01925.x","volume":"65","author":"G Weiss","year":"2007","unstructured":"Weiss G, Madsen HO, Garred P. A novel mannose-binding lectin-associated serine protease 1\/3 gene variant. Scand J Immunol. 2007;65:430\u20134. https:\/\/doi.org\/10.1111\/j.1365-3083.2007.01925.x.","journal-title":"Scand J Immunol"},{"key":"2172_CR36","doi-asserted-by":"publisher","first-page":"10432","DOI":"10.1111\/jcmm.15656","volume":"24","author":"W-D Xu","year":"2020","unstructured":"Xu W-D, Liu X-Y, Su L-C, et al. Association of MASP2 levels and MASP2 gene polymorphisms with systemic lupus erythematosus. J Cell Mol Med. 2020;24:10432\u201343. https:\/\/doi.org\/10.1111\/jcmm.15656.","journal-title":"J Cell Mol Med"},{"key":"2172_CR37","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s10875-019-00714-4","volume":"40","author":"MI Garc\u00eda-Laorden","year":"2020","unstructured":"Garc\u00eda-Laorden MI, Hern\u00e1ndez-Brito E, Mu\u00f1oz-Almagro C, et al. Should masp-2 deficiency be considered a primary immunodeficiency? Relevance of the lectin pathway. J Clin Immunol. 2020;40:203\u201310. https:\/\/doi.org\/10.1007\/s10875-019-00714-4.","journal-title":"J Clin Immunol"},{"key":"2172_CR38","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.rbre.2016.01.002","volume":"56","author":"SF Perazzio","year":"2016","unstructured":"Perazzio SF, Silva NPd, Carneiro-Sampaio M, et al. Mild and moderate mannose binding lectin deficiency are associated with systemic lupus erythematosus and lupus nephritis in Brazilian patients. Rev Bras Reumatol (Engl Ed). 2016;56:220\u20137. https:\/\/doi.org\/10.1016\/j.rbre.2016.01.002.","journal-title":"Rev Bras Reumatol (Engl Ed)"},{"key":"2172_CR39","first-page":"45","volume":"27","author":"RA Rabie","year":"2020","unstructured":"Rabie RA, Ibrahim NF, Gebriel MG. Mannose-binding lectin serum level and gene polymorphism in systemic lupus erythematosus Egyptian patients. Egypt J Immunol. 2020;27:45\u201353.","journal-title":"Egypt J Immunol"},{"key":"2172_CR40","doi-asserted-by":"publisher","first-page":"R218","DOI":"10.1186\/ar4057","volume":"14","author":"AK Panda","year":"2012","unstructured":"Panda AK, Parida JR, Tripathy R, et al. Mannose binding lectin: a biomarker of systemic lupus erythematosus disease activity. Arthritis Res Ther. 2012;14:R218. https:\/\/doi.org\/10.1186\/ar4057.","journal-title":"Arthritis Res Ther"},{"key":"2172_CR41","doi-asserted-by":"crossref","first-page":"11","DOI":"10.5005\/japi-11001-0110","volume":"70","author":"G Thakur","year":"2022","unstructured":"Thakur G, Madan T, Surve P, et al. Mannose binding lectin levels and its association with systemic lupus erythematosus disease severity: An indian report. J Assoc Physicians India. 2022;70:11\u20132.","journal-title":"J Assoc Physicians India"},{"key":"2172_CR42","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.3899\/jrheum.171033","volume":"45","author":"A Troldborg","year":"2018","unstructured":"Troldborg A, Thiel S, Trendelenburg M, et al. The lectin pathway of complement activation in patients with systemic lupus erythematosus. J Rheumatol. 2018;45:1136\u201344. https:\/\/doi.org\/10.3899\/jrheum.171033.","journal-title":"J Rheumatol"},{"key":"2172_CR43","doi-asserted-by":"publisher","first-page":"885","DOI":"10.3389\/fimmu.2019.00885","volume":"10","author":"SL Savelli","year":"2019","unstructured":"Savelli SL, Roubey RAS, Kitzmiller KJ, et al. Opposite profiles of complement in antiphospholipid syndrome (APS) and systemic lupus erythematosus (SLE) among patients with antiphospholipid antibodies (apl). Front Immunol. 2019;10:885. https:\/\/doi.org\/10.3389\/fimmu.2019.00885.","journal-title":"Front Immunol"},{"key":"2172_CR44","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1111\/1756-185X.13249","volume":"21","author":"S Didel","year":"2018","unstructured":"Didel S, Suri D, Rawat A, et al. Functional mannose binding lectin levels in patients with pediatric onset systemic lupus erythematosus in remission. Int J Rheum Dis. 2018;21:710\u20135. https:\/\/doi.org\/10.1111\/1756-185X.13249.","journal-title":"Int J Rheum Dis"},{"key":"2172_CR45","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1136\/ard.2005.046086","volume":"65","author":"S Saevarsdottir","year":"2006","unstructured":"Saevarsdottir S, Kristjansdottir H, Grondal G, et al. Mannan-binding lectin and complement C4A in Icelandic multicase families with systemic lupus erythematosus. Ann Rheum Dis. 2006;65:1462\u20137. https:\/\/doi.org\/10.1136\/ard.2005.046086.","journal-title":"Ann Rheum Dis"},{"key":"2172_CR46","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1007\/s00296-012-2588-9","volume":"33","author":"V Pradhan","year":"2013","unstructured":"Pradhan V, Mahant G, Rajadhyaksha A, et al. A study on anti-mannose binding lectin (anti-MBL) antibodies and serum MBL levels in indian systemic lupus erythematosus patients. Rheumatol Int. 2013;33:1533\u20139. https:\/\/doi.org\/10.1007\/s00296-012-2588-9.","journal-title":"Rheumatol Int"},{"key":"2172_CR47","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.3899\/jrheum.131470","volume":"41","author":"I R\u00faa-Figueroa","year":"2014","unstructured":"R\u00faa-Figueroa I, N\u00f3voa J, Garc\u00eda-Laorden MI, et al. Clinical and immunogenetic factors associated with pneumonia in patients with systemic lupus erythematosus: a case-control study. J Rheumatol. 2014;41:1801\u20137. https:\/\/doi.org\/10.3899\/jrheum.131470.","journal-title":"J Rheumatol"},{"key":"2172_CR48","doi-asserted-by":"publisher","first-page":"3337","DOI":"10.1007\/s10067-022-06285-x","volume":"41","author":"B Musunuri","year":"2022","unstructured":"Musunuri B, Tripathy R, Padhi S, et al. The role of MBL, pct, CRP, neutrophil-lymphocyte ratio, and platelet lymphocyte ratio in differentiating infections from flares in lupus. Clin Rheumatol. 2022;41:3337\u201344. https:\/\/doi.org\/10.1007\/s10067-022-06285-x.","journal-title":"Clin Rheumatol"},{"key":"2172_CR49","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1177\/0961203317722846","volume":"27","author":"JZ Cieslinski","year":"2018","unstructured":"Cieslinski JZ, Skare TL, Nisihara R, et al. Mannose-binding lectin serum levels in patients with systemic lupus erythematosus: association with thrombocytopaenia and seizure. Lupus. 2018;27:372\u20139. https:\/\/doi.org\/10.1177\/0961203317722846.","journal-title":"Lupus"},{"key":"2172_CR50","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/cei.12678","volume":"182","author":"A Troldborg","year":"2015","unstructured":"Troldborg A, Thiel S, Jensen L, et al. Collectin liver 1 and collectin kidney 1 and other complement-associated pattern recognition molecules in systemic lupus erythematosus. Clin Exp Immunol. 2015;182:132\u20138. https:\/\/doi.org\/10.1111\/cei.12678.","journal-title":"Clin Exp Immunol"},{"key":"2172_CR51","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2106647118","author":"K Juul-Madsen","year":"2021","unstructured":"Juul-Madsen K, Troldborg A, Wittenborn TR, et al. Characterization of DNA-protein complexes by nanoparticle tracking analysis and their association with systemic lupus erythematosus. Proc Natl Acad Sci U S A. 2021. https:\/\/doi.org\/10.1073\/pnas.2106647118.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2172_CR52","doi-asserted-by":"publisher","first-page":"1081942","DOI":"10.3389\/fimmu.2022.1081942","volume":"13","author":"B Zhang","year":"2022","unstructured":"Zhang B, Xing G. Thrombotic microangiopathy mediates poor prognosis among lupus nephritis via complement lectin and alternative pathway activation. Front Immunol. 2022;13:1081942. https:\/\/doi.org\/10.3389\/fimmu.2022.1081942.","journal-title":"Front Immunol"},{"key":"2172_CR53","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.humimm.2013.04.030","volume":"74","author":"RM Nisihara","year":"2013","unstructured":"Nisihara RM, Magrini F, Mocelin V, et al. Deposition of the lectin pathway of complement in renal biopsies of lupus nephritis patients. Hum Immunol. 2013;74:907\u201310. https:\/\/doi.org\/10.1016\/j.humimm.2013.04.030.","journal-title":"Hum Immunol"},{"key":"2172_CR54","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1177\/0961203311415561","volume":"20","author":"N Sato","year":"2011","unstructured":"Sato N, Ohsawa I, Nagamachi S, et al. Significance of glomerular activation of the alternative pathway and lectin pathway in lupus nephritis. Lupus. 2011;20:1378\u201386. https:\/\/doi.org\/10.1177\/0961203311415561.","journal-title":"Lupus"},{"key":"2172_CR55","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.humimm.2014.04.015","volume":"75","author":"LR Wallim","year":"2014","unstructured":"Wallim LR, Nisihara R, Skare T, et al. Mannose binding lectin deposition in skin of lupus erythematosus patients: a case series. Hum Immunol. 2014;75:629\u201332. https:\/\/doi.org\/10.1016\/j.humimm.2014.04.015.","journal-title":"Hum Immunol"},{"key":"2172_CR56","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1002\/mus.27636","volume":"66","author":"Y Fukami","year":"2022","unstructured":"Fukami Y, Koike H, Iijima M, et al. Role of complement components in vasculitic neuropathy associated with systemic lupus erythematosus and rheumatoid arthritis. Muscle Nerve. 2022;66:175\u201382. https:\/\/doi.org\/10.1002\/mus.27636.","journal-title":"Muscle Nerve"},{"key":"2172_CR57","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1007\/s10165-012-0616-y","volume":"22","author":"H Watanabe","year":"2012","unstructured":"Watanabe H, Saito R, Asano T, et al. Serum L-ficolin levels in patients with systemic lupus erythematosus. Mod Rheumatol. 2012;22:899\u2013902. https:\/\/doi.org\/10.1007\/s10165-012-0616-y.","journal-title":"Mod Rheumatol"},{"key":"2172_CR58","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.molimm.2014.07.003","volume":"63","author":"E Hein","year":"2015","unstructured":"Hein E, Nielsen LA, Nielsen CT, et al. Ficolins and the lectin pathway of complement in patients with systemic lupus erythematosus. Mol Immunol. 2015;63:209\u201314. https:\/\/doi.org\/10.1016\/j.molimm.2014.07.003.","journal-title":"Mol Immunol"},{"key":"2172_CR59","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s10067-016-3508-2","volume":"36","author":"N Tanha","year":"2017","unstructured":"Tanha N, Pilely K, Faurschou M, et al. Plasma ficolin levels and risk of nephritis in danish patients with systemic lupus erythematosus. Clin Rheumatol. 2017;36:335\u201341. https:\/\/doi.org\/10.1007\/s10067-016-3508-2.","journal-title":"Clin Rheumatol"},{"key":"2172_CR60","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1002\/acr.23449","volume":"70","author":"S Colliard","year":"2018","unstructured":"Colliard S, Jourde-Chiche N, Clavarino G, et al. Autoantibodies targeting ficolin-2 in systemic lupus erythematosus patients with active nephritis. Arthritis Care Res. 2018;70:1263\u20138. https:\/\/doi.org\/10.1002\/acr.23449.","journal-title":"Arthritis Care Res"},{"key":"2172_CR61","doi-asserted-by":"publisher","first-page":"948","DOI":"10.3899\/jrheum.141163","volume":"42","author":"A Troldborg","year":"2015","unstructured":"Troldborg A, Thiel S, Laska MJ, et al. Levels in plasma of the serine proteases and associated proteins of the lectin pathway are altered in patients with systemic lupus erythematosus. J Rheumatol. 2015;42:948\u201351. https:\/\/doi.org\/10.3899\/jrheum.141163.","journal-title":"J Rheumatol"},{"key":"2172_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e19072","volume":"9","author":"Y Asanuma","year":"2023","unstructured":"Asanuma Y, Nozawa K, Matsushita M, et al. Critical role of lectin pathway mediated by MBL-associated serine proteases in complement activation for the pathogenesis in systemic lupus erythematosus. Heliyon. 2023;9:e19072. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e19072.","journal-title":"Heliyon"},{"key":"2172_CR63","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41392-025-02168-0","volume":"10","author":"X Dai","year":"2025","unstructured":"Dai X, Fan Y, Zhao X. Systemic lupus erythematosus: updated insights on the pathogenesis, diagnosis, prevention and therapeutics. Signal Transduct Target Ther. 2025;10:102. https:\/\/doi.org\/10.1038\/s41392-025-02168-0.","journal-title":"Signal Transduct Target Ther"},{"key":"2172_CR64","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1681\/ASN.2017050544","volume":"29","author":"W Wu","year":"2018","unstructured":"Wu W, Liu C, Farrar CA, et al. Collectin-11 promotes the development of renal tubulointerstitial fibrosis. J Am Soc Nephrol. 2018;29:168\u201381. https:\/\/doi.org\/10.1681\/ASN.2017050544.","journal-title":"J Am Soc Nephrol"},{"key":"2172_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2022.102979","volume":"137","author":"SL Coss","year":"2023","unstructured":"Coss SL, Zhou D, Chua GT, et al. The complement system and human autoimmune diseases. J Autoimmun. 2023;137:102979. https:\/\/doi.org\/10.1016\/j.jaut.2022.102979.","journal-title":"J Autoimmun"},{"key":"2172_CR66","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/j.0300-9475.2004.01437.x","volume":"60","author":"S Saevarsdottir","year":"2004","unstructured":"Saevarsdottir S, Vikingsdottir T, Valdimarsson H. The potential role of mannan-binding lectin in the clearance of self-components including immune complexes. Scand J Immunol. 2004;60:23\u20139. https:\/\/doi.org\/10.1111\/j.0300-9475.2004.01437.x.","journal-title":"Scand J Immunol"},{"key":"2172_CR67","doi-asserted-by":"publisher","first-page":"2853","DOI":"10.1002\/eji.200323888","volume":"33","author":"AJ Nauta","year":"2003","unstructured":"Nauta AJ, Raaschou-Jensen N, Roos A, et al. Mannose-binding lectin engagement with late apoptotic and necrotic cells. Eur J Immunol. 2003;33:2853\u201363. https:\/\/doi.org\/10.1002\/eji.200323888.","journal-title":"Eur J Immunol"},{"key":"2172_CR68","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.humimm.2006.02.030","volume":"67","author":"LH Bouwman","year":"2006","unstructured":"Bouwman LH, Roep BO, Roos A. Mannose-binding lectin: clinical implications for infection, transplantation, and autoimmunity. Hum Immunol. 2006;67:247\u201356. https:\/\/doi.org\/10.1016\/j.humimm.2006.02.030.","journal-title":"Hum Immunol"},{"key":"2172_CR69","first-page":"2157","volume":"6","author":"M-K Kim","year":"2013","unstructured":"Kim M-K, Maeng Y-I, Lee S-J, et al. Pathogenesis and significance of glomerular C4d deposition in lupus nephritis: activation of classical and lectin pathways. Int J Clin Exp Pathol. 2013;6:2157\u201367.","journal-title":"Int J Clin Exp Pathol"},{"key":"2172_CR70","doi-asserted-by":"publisher","first-page":"2978","DOI":"10.1002\/art.39273","volume":"67","author":"F Vu\u010dkovi\u0107","year":"2015","unstructured":"Vu\u010dkovi\u0107 F, Kri\u0161ti\u0107 J, Gudelj I, et al. Association of systemic lupus erythematosus with decreased immunosuppressive potential of the igg glycome. Arthritis Rheumatol. 2015;67:2978\u201389. https:\/\/doi.org\/10.1002\/art.39273.","journal-title":"Arthritis Rheumatol"},{"key":"2172_CR71","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.autrev.2008.06.002","volume":"8","author":"M Kavai","year":"2008","unstructured":"Kavai M. Immune complex clearance by complement receptor type 1 in SLE. Autoimmun Rev. 2008;8:160\u20134. https:\/\/doi.org\/10.1016\/j.autrev.2008.06.002.","journal-title":"Autoimmun Rev"},{"key":"2172_CR72","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1136\/annrheumdis-2012-201390","volume":"71","author":"B Rhodes","year":"2012","unstructured":"Rhodes B, F\u00fcrnrohr BG, Roberts AL, et al. The rs1143679 (R77H) lupus associated variant of itgam (CD11b) impairs complement receptor 3 mediated functions in human monocytes. Ann Rheum Dis. 2012;71:2028\u201334. https:\/\/doi.org\/10.1136\/annrheumdis-2012-201390.","journal-title":"Ann Rheum Dis"},{"key":"2172_CR73","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1136\/annrheumdis-2014-205584","volume":"75","author":"J Zhao","year":"2016","unstructured":"Zhao J, Giles BM, Taylor RL, et al. Preferential association of a functional variant in complement receptor 2 with antibodies to double-stranded DNA. Ann Rheum Dis. 2016;75:242\u201352. https:\/\/doi.org\/10.1136\/annrheumdis-2014-205584.","journal-title":"Ann Rheum Dis"},{"key":"2172_CR74","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/s41581-023-00766-1","volume":"19","author":"V Petr","year":"2023","unstructured":"Petr V, Thurman JM. The role of complement in kidney disease. Nat Rev Nephrol. 2023;19:771\u201387. https:\/\/doi.org\/10.1038\/s41581-023-00766-1.","journal-title":"Nat Rev Nephrol"},{"key":"2172_CR75","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/s41577-023-00926-1","volume":"24","author":"DC Mastellos","year":"2024","unstructured":"Mastellos DC, Hajishengallis G, Lambris JD. A guide to complement biology, pathology and therapeutic opportunity. Nat Rev Immunol. 2024;24:118\u201341. https:\/\/doi.org\/10.1038\/s41577-023-00926-1.","journal-title":"Nat Rev Immunol"},{"key":"2172_CR76","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.molimm.2013.07.011","volume":"56","author":"ML Henriksen","year":"2013","unstructured":"Henriksen ML, Brandt J, Iyer SSC, et al. Characterization of the interaction between collectin 11 (CL-11, CL-K1) and nucleic acids. Mol Immunol. 2013;56:757\u201367. https:\/\/doi.org\/10.1016\/j.molimm.2013.07.011.","journal-title":"Mol Immunol"},{"key":"2172_CR77","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1084\/jem.194.6.781","volume":"194","author":"CA Ogden","year":"2001","unstructured":"Ogden CA, deCathelineau A, Hoffmann PR, et al. C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells. J Exp Med. 2001;194:781\u201395. https:\/\/doi.org\/10.1084\/jem.194.6.781.","journal-title":"J Exp Med"},{"key":"2172_CR78","doi-asserted-by":"publisher","DOI":"10.1093\/jimmun\/vkaf028","author":"L Mu","year":"2025","unstructured":"Mu L, Li J, Lin Z, et al. MBL regulates phagocytosis and bactericidal activity of macrophages by triggering AKT\/NF-\u03baB\/Rab5A axis occurred early in vertebrate evolution. J Immunol. 2025. https:\/\/doi.org\/10.1093\/jimmun\/vkaf028.","journal-title":"J Immunol"},{"key":"2172_CR79","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1002\/art.22564","volume":"56","author":"C Honor\u00e9","year":"2007","unstructured":"Honor\u00e9 C, Hummelshoj T, Hansen BE, et al. The innate immune component ficolin 3 (Hakata antigen) mediates the clearance of late apoptotic cells. Arthritis Rheum. 2007;56:1598\u2013607. https:\/\/doi.org\/10.1002\/art.22564.","journal-title":"Arthritis Rheum"},{"key":"2172_CR80","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1084\/jem.192.12.1797","volume":"192","author":"I Ghiran","year":"2000","unstructured":"Ghiran I, Barbashov SF, Klickstein LB, et al. Complement receptor 1\/CD35 is a receptor for mannan-binding lectin. J Exp Med. 2000;192:1797\u2013808. https:\/\/doi.org\/10.1084\/jem.192.12.1797.","journal-title":"J Exp Med"},{"key":"2172_CR81","doi-asserted-by":"publisher","DOI":"10.3390\/biom13101522","author":"MP Hardy","year":"2023","unstructured":"Hardy MP, Mansour M, Rowe T, et al. The molecular mechanisms of complement receptor 1-it is complicated. Biomolecules. 2023. https:\/\/doi.org\/10.3390\/biom13101522.","journal-title":"Biomolecules"},{"key":"2172_CR82","doi-asserted-by":"publisher","first-page":"645","DOI":"10.4049\/jimmunol.2300457","volume":"212","author":"L Mu","year":"2024","unstructured":"Mu L, Yin X, Qiu L, et al. CL-K1 promotes complement activation and regulates opsonophagocytosis of macrophages with cd93 interaction in a primitive vertebrate. J Immunol. 2024;212:645\u201362. https:\/\/doi.org\/10.4049\/jimmunol.2300457.","journal-title":"J Immunol"},{"key":"2172_CR83","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.594858","volume":"12","author":"T Wang","year":"2021","unstructured":"Wang T, Li K, Xiao S, et al. A plausible role for collectins in skin immune homeostasis. Front Immunol. 2021;12:594858. https:\/\/doi.org\/10.3389\/fimmu.2021.594858.","journal-title":"Front Immunol"},{"key":"2172_CR84","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2024.103648","volume":"23","author":"L Arnaud","year":"2024","unstructured":"Arnaud L, Chasset F, Martin T. Immunopathogenesis of systemic lupus erythematosus: an update. Autoimmun Rev. 2024;23:103648. https:\/\/doi.org\/10.1016\/j.autrev.2024.103648.","journal-title":"Autoimmun Rev"},{"key":"2172_CR85","doi-asserted-by":"publisher","first-page":"2916","DOI":"10.4049\/jimmunol.178.5.2916","volume":"178","author":"H Ferry","year":"2007","unstructured":"Ferry H, Potter PK, Crockford TL, et al. Increased positive selection of b1 cells and reduced b cell tolerance to intracellular antigens in c1q-deficient mice. J Immunol. 2007;178:2916\u201322. https:\/\/doi.org\/10.4049\/jimmunol.178.5.2916.","journal-title":"J Immunol"},{"key":"2172_CR86","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1111\/imm.13663","volume":"170","author":"S Kareem","year":"2023","unstructured":"Kareem S, Jacob A, Mathew J, et al. Complement: functions, location and implications. Immunology. 2023;170:180\u201392. https:\/\/doi.org\/10.1111\/imm.13663.","journal-title":"Immunology"},{"key":"2172_CR87","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.958273","volume":"13","author":"K Schulz","year":"2022","unstructured":"Schulz K, Trendelenburg M. C1q as a target molecule to treat human disease: What do mouse studies teach us? Front Immunol. 2022;13:958273. https:\/\/doi.org\/10.3389\/fimmu.2022.958273.","journal-title":"Front Immunol"},{"key":"2172_CR88","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1093\/rheumatology\/40.9.1009","volume":"40","author":"J Villarreal","year":"2001","unstructured":"Villarreal J, Crosdale D, Ollier W, et al. Mannose binding lectin and fcgammariia (CD32) polymorphism in spanish systemic lupus erythematosus patients. Rheumatology. 2001;40:1009\u201312. https:\/\/doi.org\/10.1093\/rheumatology\/40.9.1009.","journal-title":"Rheumatology"},{"key":"2172_CR89","doi-asserted-by":"publisher","first-page":"1275203","DOI":"10.3389\/fimmu.2024.1275203","volume":"15","author":"YR Sheng","year":"2024","unstructured":"Sheng YR, Hu WT, Chen S, et al. Efferocytosis by macrophages in physiological and pathological conditions: regulatory pathways and molecular mechanisms. Front Immunol. 2024;15:1275203. https:\/\/doi.org\/10.3389\/fimmu.2024.1275203.","journal-title":"Front Immunol"},{"key":"2172_CR90","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/s41392-023-01471-y","volume":"8","author":"L Sun","year":"2023","unstructured":"Sun L, Su Y, Jiao A, et al. T cells in health and disease. Signal Transduct Target Ther. 2023;8:235. https:\/\/doi.org\/10.1038\/s41392-023-01471-y.","journal-title":"Signal Transduct Target Ther"},{"key":"2172_CR91","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1136\/ard-2023-225433","volume":"83","author":"AG Ferret\u00e9-Bonastre","year":"2024","unstructured":"Ferret\u00e9-Bonastre AG, Mart\u00ednez-Gallo M, Morante-Palacios O, et al. Disease activity drives divergent epigenetic and transcriptomic reprogramming of monocyte subpopulations in systemic lupus erythematosus. Ann Rheum Dis. 2024;83:865\u201378. https:\/\/doi.org\/10.1136\/ard-2023-225433.","journal-title":"Ann Rheum Dis"},{"key":"2172_CR92","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0062465","volume":"8","author":"Y Cai","year":"2013","unstructured":"Cai Y, Zhang W, Xiong S. Mannose-binding lectin blunts macrophage polarization and ameliorates lupus nephritis. PLoS ONE. 2013;8:e62465. https:\/\/doi.org\/10.1371\/journal.pone.0062465.","journal-title":"PLoS ONE"},{"key":"2172_CR93","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1096\/fj.201601200RR","volume":"31","author":"N Zhao","year":"2017","unstructured":"Zhao N, Wu J, Xiong S, et al. Mannan-binding lectin, a serum collectin, suppresses T-cell proliferation via direct interaction with cell surface calreticulin and inhibition of proximal T-cell receptor signaling. FASEB J. 2017;31:2405\u201317. https:\/\/doi.org\/10.1096\/fj.201601200RR.","journal-title":"FASEB J"},{"key":"2172_CR94","doi-asserted-by":"publisher","DOI":"10.3390\/cells12131805","author":"G Fanelli","year":"2023","unstructured":"Fanelli G, Romano M, Lombardi G, et al. Soluble collectin 11 (CL-11) acts as an immunosuppressive molecule potentially used by stem cell-derived retinal epithelial cells to modulate t cell response. Cells. 2023. https:\/\/doi.org\/10.3390\/cells12131805.","journal-title":"Cells"},{"key":"2172_CR95","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1002\/art.41696","volume":"73","author":"N Wang","year":"2021","unstructured":"Wang N, Wu W, Qiang C, et al. Protective role of collectin 11 in a mouse model of rheumatoid arthritis. Arthritis Rheumatol. 2021;73:1430\u201340. https:\/\/doi.org\/10.1002\/art.41696.","journal-title":"Arthritis Rheumatol"},{"key":"2172_CR96","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1002\/art.42482","volume":"75","author":"DM Ferri","year":"2023","unstructured":"Ferri DM, Nassar C, Manion KP, et al. Elevated levels of interferon-\u03b1 act directly on b cells to breach multiple tolerance mechanisms promoting autoantibody production. Arthritis Rheumatol. 2023;75:1542\u201355. https:\/\/doi.org\/10.1002\/art.42482.","journal-title":"Arthritis Rheumatol"},{"key":"2172_CR97","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s40265-024-02043-2","volume":"84","author":"SA Jones","year":"2024","unstructured":"Jones SA, Morand EF. Targeting interferon signalling in systemic lupus erythematosus: lessons learned. Drugs. 2024;84:625\u201335. https:\/\/doi.org\/10.1007\/s40265-024-02043-2.","journal-title":"Drugs"},{"key":"2172_CR98","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2023.131193","volume":"389","author":"S Zhang","year":"2023","unstructured":"Zhang S, Yang L, Guo S, et al. Mannose binding lectin-associated serine protease-1 is a novel contributor to myocardial ischemia\/reperfusion injury. Int J Cardiol. 2023;389:131193. https:\/\/doi.org\/10.1016\/j.ijcard.2023.131193.","journal-title":"Int J Cardiol"},{"key":"2172_CR99","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1128\/CVI.00527-09","volume":"17","author":"JT Friborg","year":"2010","unstructured":"Friborg JT, Jarrett RF, Koch A, et al. Mannose-binding lectin genotypes and susceptibility to epstein-barr virus infection in infancy. Clin Vaccine Immunol. 2010;17:1484\u20137. https:\/\/doi.org\/10.1128\/CVI.00527-09.","journal-title":"Clin Vaccine Immunol"},{"key":"2172_CR100","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.intimp.2011.01.013","volume":"11","author":"RE Seeds","year":"2011","unstructured":"Seeds RE, Mukhopadhyay S, Jones IM, et al. The role of myeloid receptors on murine plasmacytoid dendritic cells in induction of type i interferon. Int Immunopharmacol. 2011;11:794\u2013801. https:\/\/doi.org\/10.1016\/j.intimp.2011.01.013.","journal-title":"Int Immunopharmacol"},{"key":"2172_CR101","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1002\/art.43019","volume":"77","author":"MJ Kaplan","year":"2025","unstructured":"Kaplan MJ. Exploring the role of neutrophil extracellular traps in systemic lupus erythematosus: a clinical case study and comprehensive review. Arthritis Rheumatol. 2025;77:247\u201352. https:\/\/doi.org\/10.1002\/art.43019.","journal-title":"Arthritis Rheumatol"},{"key":"2172_CR102","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70101","volume":"6","author":"L Zeng","year":"2025","unstructured":"Zeng L, Xiang W, Xiao W, et al. The emerging role of neutrophil extracellular traps in autoimmune and autoinflammatory diseases. MedComm. 2025;6:e70101. https:\/\/doi.org\/10.1002\/mco2.70101.","journal-title":"MedComm"},{"key":"2172_CR103","doi-asserted-by":"publisher","first-page":"1159577","DOI":"10.3389\/fimmu.2023.1159577","volume":"14","author":"L Mu","year":"2023","unstructured":"Mu L, Yin X, Bai H, et al. Mannose-binding lectin suppresses macrophage proliferation through tgf-\u03b21 signaling pathway in Nile tilapia. Front Immunol. 2023;14:1159577. https:\/\/doi.org\/10.3389\/fimmu.2023.1159577.","journal-title":"Front Immunol"},{"key":"2172_CR104","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1189\/jlb.1105683","volume":"80","author":"DA Fraser","year":"2006","unstructured":"Fraser DA, Bohlson SS, Jasinskiene N, et al. C1q and MBL, components of the innate immune system, influence monocyte cytokine expression. J Leukoc Biol. 2006;80:107\u201316. https:\/\/doi.org\/10.1189\/jlb.1105683.","journal-title":"J Leukoc Biol"},{"key":"2172_CR105","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/cmi.2011.1","volume":"8","author":"M Wang","year":"2011","unstructured":"Wang M, Chen Y, Zhang Y, et al. Mannan-binding lectin directly interacts with toll-like receptor 4 and suppresses lipopolysaccharide-induced inflammatory cytokine secretion from thp-1 cells. Cell Mol Immunol. 2011;8:265\u201375. https:\/\/doi.org\/10.1038\/cmi.2011.1.","journal-title":"Cell Mol Immunol"},{"key":"2172_CR106","doi-asserted-by":"publisher","first-page":"e22227","DOI":"10.1096\/fj.202101852R","volume":"36","author":"Y Ma","year":"2022","unstructured":"Ma Y, Cai F, Huang X, et al. Mannose-binding lectin activates the nuclear factor-\u03bab and renal inflammation in the progression of diabetic nephropathy. FASEB J. 2022;36:e22227. https:\/\/doi.org\/10.1096\/fj.202101852R.","journal-title":"FASEB J"},{"key":"2172_CR107","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/6738286","volume":"2019","author":"J Zhou","year":"2019","unstructured":"Zhou J, Hu M, Li J, et al. Mannan-binding lectin regulates inflammatory cytokine production, proliferation, and cytotoxicity of human peripheral natural killer cells. Mediators Inflamm. 2019;2019:6738286. https:\/\/doi.org\/10.1155\/2019\/6738286.","journal-title":"Mediators Inflamm"},{"key":"2172_CR108","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24119181","author":"Z N\u00e9meth","year":"2023","unstructured":"N\u00e9meth Z, Debreczeni ML, Kajd\u00e1csi E, et al. Cooperation of complement MASP-1 with other proinflammatory factors to enhance the activation of endothelial cells. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms24119181.","journal-title":"Int J Mol Sci"},{"key":"2172_CR109","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1200\/JCO.21.02389","volume":"40","author":"SK Khaled","year":"2022","unstructured":"Khaled SK, Claes K, Goh YT, et al. Narsoplimab, a mannan-binding lectin-associated serine protease-2 inhibitor, for the treatment of adult hematopoietic stem-cell transplantation-associated thrombotic microangiopathy. J Clin Oncol. 2022;40:2447\u201357. https:\/\/doi.org\/10.1200\/JCO.21.02389.","journal-title":"J Clin Oncol"},{"key":"2172_CR110","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1016\/j.ekir.2020.08.003","volume":"5","author":"RA Lafayette","year":"2020","unstructured":"Lafayette RA, Rovin BH, Reich HN, et al. Safety, tolerability and efficacy of narsoplimab, a novel masp-2 inhibitor for the treatment of iga nephropathy. Kidney Int Rep. 2020;5:2032\u201341. https:\/\/doi.org\/10.1016\/j.ekir.2020.08.003.","journal-title":"Kidney Int Rep"},{"key":"2172_CR111","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1124\/pharmrev.120.000072","volume":"73","author":"P Garred","year":"2021","unstructured":"Garred P, Tenner AJ, Mollnes TE. Therapeutic targeting of the complement system: from rare diseases to pandemics. Pharmacol Rev. 2021;73:792\u2013827. https:\/\/doi.org\/10.1124\/pharmrev.120.000072.","journal-title":"Pharmacol Rev"},{"key":"2172_CR112","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.3389\/fimmu.2018.01191","volume":"9","author":"T Machida","year":"2018","unstructured":"Machida T, Sakamoto N, Ishida Y, et al. Essential roles for mannose-binding lectin-associated serine protease-1\/3 in the development of lupus-like glomerulonephritis in mrl\/lpr mice. Front Immunol. 2018;9:1191. https:\/\/doi.org\/10.3389\/fimmu.2018.01191.","journal-title":"Front Immunol"}],"container-title":["Inflammation Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-025-02172-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00011-025-02172-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-025-02172-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T02:29:20Z","timestamp":1772072960000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00011-025-02172-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,26]]},"references-count":112,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2172"],"URL":"https:\/\/doi.org\/10.1007\/s00011-025-02172-8","relation":{},"ISSN":["1420-908X"],"issn-type":[{"value":"1420-908X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,26]]},"assertion":[{"value":"1 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have declared that no conflict of interest exists.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"44"}}